3 quality blue chip ASX 200 shares analysts are tipping as buys

Here are three quality ASX 200 shares rated as buys…

| More on:
Person holding a blue chip.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors that are looking for some new shares to buy might want to look at the blue chips listed below.

These three blue chip ASX 200 shares have been tipped to climb meaningfully higher from where they trade today. Here’s what you have to know about them:

CSL Limited (ASX: CSL)

The first blue chip for investors to look at is one of the world’s leading biotechnology companies. CSL comprises the CSL Behring and Seqirus businesses, which are leaders in their respective fields – plasma therapies and vaccines. The company is also aiming to acquire Vifor Pharma in a blockbuster deal that will expand its product portfolio and pipeline. All in all, this deal, its billion-dollar per annum spend on R&D, and improving plasma collections, appear to have positioned CSL well for long term growth.

Yesterday the team at Citi retained its buy rating and $335.00 price target on CSL’s shares. Its analysts believe that plasma collections will bounce back beyond pre-pandemic levels this year. Citi expects this to be a big boost to investor sentiment.

Goodman Group (ASX: GMG)

Another blue chip ASX 200 share that could be in the buy zone is Goodman. It is a global integrated commercial and industrial property company with a world class property portfolio. These properties have exposure to key growth markets such as ecommerce and are in high demand. Thanks to this strong demand and its lucrative development pipeline, Goodman has been tipped to continue its strong growth long into the future.

Citi is also positive on Goodman’s future. Its analysts currently have a buy rating and $29.50 price target on its shares. The broker recently stated that it expects Goodman to outperform its upgraded earnings guidance in FY 2022.

ResMed Inc. (ASX: RMD)

A final blue chip ASX 200 share to look at is ResMed. It is a sleep treatment focused medical device company which has been tipped to continue its stellar growth long into the future. This is thanks to its world class products, significant market opportunity, the growing prevalence of sleep disorders, and, as Morgans highlights, its “unique, patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain.”

It is partly because of the latter that Morgans is positive on the company and has an add rating and $40.46 price target on its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns and has recommended CSL Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads news about the top ASX 200 shares today
Blue Chip Shares

Brokers name 2 blue chip ASX 200 shares to buy

Here are two blue chip ASX 200 shares to buy...

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Blue Chip Shares

Brokers say BHP and this ASX 200 share are buys

Here are two ASX 200 shares rated as buys....

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Blue Chip Shares

2 blue chip ASX 200 shares tipped as buys by experts

These blue chip have been rated as buys...

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Blue Chip Shares

2 ASX 200 blue chip shares brokers rate as buys

Here are two ASX 200 shares to buy...

Read more »

A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
Blue Chip Shares

Expert says Telstra is a blue chip ASX 200 share to buy

Telstra could be an ASX 200 share to buy...

Read more »

Group of smiling coal miners in a coal mine
Blue Chip Shares

Clearly this is one of the cheapest ASX 200 stocks

Although the Whitehaven Coal share price has already soared 130% in 2022, it still looks incredibly cheap.

Read more »

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads news about the top ASX 200 shares today
Blue Chip Shares

2 blue chip ASX 200 shares analysts rate as buys

These blue chip shares could be buys in August...

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Broker names 3 ASX 200 shares to buy and hold

Here are three top shares for buy and hold investors...

Read more »